Adaptive Biotechnologies (ADPT) Tops Q4 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $25.51 +4.51%
EPS Growth %: -250.0%
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: -250.0%
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 EPS of ($0.09), $0.09 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $71.7 million versus the consensus estimate of $59.33 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kotak Upgrades Indusind Bank Ltd (IIB:IN) to Reduce (3)
- Oppenheimer Reiterates Outperform Rating on Amgen (AMGN)
- IndeRes Upgrades Nokia OYJ (NOKIA:FH) (NOK) to Reduce (3)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
